The page is the record's research on the issuer — no analyst, no rating, no view.

Braveheart Bio, Inc. (BRVE) — research page

US · us-cm-kg/NASDAQ/BRVE · as of 2026-11-08

Identity and listing

The issuer is Braveheart Bio, Inc., listed on NASDAQ under ticker BRVE, with ISIN US10567X1019; its LEI is not on the record, as no GLEIF record carries the exact legal name in jurisdiction US-DE. Its security type is Corporate, its segment is not on the record, its sector is 2834 Pharmaceutical Preparations, and its jurisdiction is United States, Delaware. The issuer is listed and not halted.

fieldvaluesource · read date
nameBraveheart Bio, Inc.source · 2026-11-08
exchangeNASDAQsource · 2026-11-08
tickerBRVEsource · 2026-11-08
ISINUS10567X1019source · 2026-10-13
LEInot on the record
security typeCorporatesource · 2026-11-08
segmentnot on the record
sector2834 Pharmaceutical Preparationssource · 2026-11-08
jurisdictionUnited States — Delawaresource · 2026-11-08
statuslisted, not haltedsource · 2026-11-08

The disclosure read

The record holds 48 filings in the twelve months to 2026-11-08, across 16 filing days. The median gap between filing days is 3 days. The latest filing is dated 2026-11-06, two days before the record date, and is of type corporate_news. On NASDAQ the median filings count is 52, the median cadence gap is 6.0 days and the median latency is 5.0 days across 4359 issuers. In the sector 2834 Pharmaceutical Preparations the median filings count is 63.0, the median cadence gap is 6.0 days and the median latency is 4.0 days across 526 issuers. The issuer's filings by type are 29 directors_dealings, 11 regulatory_filing, 4 prospectus, 2 results, 1 ad_hoc and 1 corporate_news.

filingsmedian gap between filing daysdays from latest filing to as-of
this issuer4832
exchange median: NASDAQ (4359 issuers)5265
sector median: 2834 Pharmaceutical Preparations (526 issuers)6364
datetypecategoryfiling
2026-11-06corporate_news8-K8-K — 8-K (items 7.01,9.01)
2026-11-05regulatory_filingSCHEDULE 13GSCHEDULE 13G
2026-09-10regulatory_filingSCHEDULE 13D/ASCHEDULE 13D/A
2026-09-08results10-Q10-Q — 10-Q
2026-09-08results8-K8-K — 8-K (items 2.02,9.01)

window 2025-11-08 to 2026-11-08 · the node's disclosure lines, as get_filings serves them

Auditor

The auditor is not on the record, as the latest annual report cover carries no dei:AuditorName tag, and its location is not on the record. The record holds no auditor changes.

Events and halts

The record holds two listing lines, dated 2026-08-03 and 2026-08-06. It holds no delisting, name change or domicile change lines, and the segment move is not on the record. The halt flag is not set.

Orderability

The outcome is not determinable, as the chapter's orderability section carries no client categories and so the outcome cannot name its client category. The rule version is acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1, and the chapter is as of 2026-11-04.

rule acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1 · chapter as of 2026-11-04 · the full outcome: get_orderability

Coverage

No research houses were found on the issuer's investor-relations page.

Open research

No openly published research notes were found on the record.

Licensed

Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.

licensorentitlementtitledatesource
none loaded

As-of depth

The record holds the issuer's 2026 year as sealed. The market's earliest sealed date is 2021-01-04, and the live record for the issuer began on 2026-09-12.

Sources

7 source pages are named on this page; every value above carries its own source page and read date in the numbers.

10.1
https://www.sec.gov/files/company_tickers_exchange.json (identity.exchange)
10.2
https://www.sec.gov/data-research/sec-markets-data/fails-deliver-data (identity.isin)
10.3
https://data.sec.gov/submissions/CIK0002131524.json (identity.jurisdiction)
10.4
https://mcp.us-cm-kg.ai/events/NASDAQ/BRVE (the disclosure lines)
10.5
https://www.nasdaqtrader.com/rss.aspx?feed=tradehalts (the halt flag)
10.6
https://mcp.us-cm-kg.ai/book/aio.json (the orderability chapter)
10.7
https://mcp.us-cm-kg.ai/record/NASDAQ/BRVE (the record)

Read it by agent

The same page, signed and receipted: get_research at https://mcp.getresearch.ai/mcp with {"isin":"US10567X1019"}. Twins: .md · .json. Written: Claude through the platform account, Haiku class; one pass; checked against the numbers. Page hash sha256:1f8cf91e12a2f319.